Loading...

loading icon

Aphria invests in Scientus to tap Canadian MJ extracts market

by / No Comments / 0 View / August 16, 2017

By Matt Lamers

Aphria is increasing its stake in the booming cannabinoid-based extracts market with an 11.5 million Canadian dollar ($9 million) investment in Scientus Pharma, a vertically integrated biopharmaceutical company.

Toronto-based Scientus Pharma conducts research and product development related to medical cannabinoids and their derivatives. The investment is in the form of senior, secured convertible debt.

Aphria (Toronto Stock Exchange: APH), based in Leamington, Ontario, said the investment also gives it access to Scientus’ so-called dealer’s license. The holder of such a license is permitted to buy, process and sell cannabinoid derivatives in international markets.

Canada’s medical marijuana market has

Aphria invests in Scientus to tap Canadian MJ extracts market is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

…read more

Via: Aphria invests in Scientus to tap Canadian MJ extracts market